SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001839882-24-014966
Filing Date
2024-05-09
Accepted
2024-05-09 08:00:25
Documents
7
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT cntsa-def14a_062524.htm DEF 14A 1986242
2 GRAPHIC cntsa-def14a_062524img001.gif GRAPHIC 102431
3 GRAPHIC cntsa-def14a_062524img002.gif GRAPHIC 23966
4 GRAPHIC cntsa-def14a_062524img003.gif GRAPHIC 35480
5 GRAPHIC cntsa-def14a_062524img004.gif GRAPHIC 27027
6 GRAPHIC cntsa-def14a_062524img005.gif GRAPHIC 7719
7 GRAPHIC cntsa-def14a_062524img006.gif GRAPHIC 247309
  Complete submission text file 0001839882-24-014966.txt   2598603
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40445 | Film No.: 24928666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)